You are here: Industry Insights > Inc

News List

European Commission approves Novartis’ Xolair® (omalizumab) europeanpharmaceuticalreview
August 10, 2020
Novartis’ Xolair (omalizumab) has been approved by the European Commission as an add-on therapy with intranasal corticosteroids to treat severe chronic rhinosinusitis with nasal polyps.
Syneos offers predictions for 2019 fiercepharma
November 27, 2018
With 2018 almost in the bag, it’s time to look to the pharma trends percolating for 2019. Back for another gander into the crystal ball is Syneos Health, formerly InVentiv Health pre-merger with INC Research, with its latest annual prognosticating report
INC Research and inVentiv Health announce successful completion of merger pharmaasia
August 15, 2017
Combination creates the only fully integrated biopharmaceutical solutions organization with combined net revenue of more than US$3 billion.
INC Research Expands in Japan contractpharma
June 30, 2017
New office to support growth strategy in Asia/Pacific market